Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Genetic engineering of a modified herpes simplex virus 1 vaccine vector.

Genetic engineering of a modified herpes simplex virus 1 vaccine vector. Vaccine. 2009 May 11; 27(21):2760-7.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.